Literature DB >> 12084533

Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist.

Insug O1, Laszlo Otvos, Thomas Kieber-Emmons, Magdalena Blaszczyk-Thurin.   

Abstract

E-selectin ligand Sialyl-Lewis a (SA-Le(a)) carbohydrate is expressed on many carcinomas. Peptide mimicking SA-Le(a) (DLWDWVVGKPAG) was previously selected from a recombinant library by screening with monoclonal antibody (MAb) NS19-9. In this study, the residues critical for interaction with the NS19-9 were mapped using peptide array generated by substitution of various amino acid residues. The replacement of Trp 5 with Phe resulted in a change of peptide's secondary structure and increased binding with MAb and E-selectin, suggesting improved carbohydrate mimicry. Colonization of tumor cells expressing SA-Le(a) was blocked by the peptide and was completely abolished in E-selectin knock out mice. The data suggest the critical role of carbohydrate antigens and E-selectin in metastasis and that peptides mimicking carbohydrate antigens can function as antagonists of this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084533     DOI: 10.1016/s0196-9781(02)00024-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

1.  Vascular density and endothelial cell expression of integrin alpha v beta 3 and E-selectin in murine tumours.

Authors:  Johanne Seguin; Céline Nicolazzi; Nathalie Mignet; Daniel Scherman; Guy G Chabot
Journal:  Tumour Biol       Date:  2012-06-07

2.  Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.

Authors:  Shingo Hatakeyama; Kazuhiro Sugihara; Toshiaki K Shibata; Jun Nakayama; Tomoya O Akama; Naoaki Tamura; Shuk-Man Wong; Andrey A Bobkov; Yutaka Takano; Chikara Ohyama; Minoru Fukuda; Michiko N Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-23       Impact factor: 11.205

3.  Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion.

Authors:  Xiaoyan Yin; Kuldeepsinh Rana; Varun Ponmudi; Michael R King
Journal:  Carbohydr Res       Date:  2010-07-21       Impact factor: 2.104

Review 4.  Antibodies: At The Nexus of Antigens and Cancer Vaccines.

Authors:  Zenon Steplewski; Magdalena Thurin; Thomas Kieber-Emmons
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

Review 5.  Regulation of the metastatic cell phenotype by sialylated glycans.

Authors:  Matthew J Schultz; Amanda F Swindall; Susan L Bellis
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 6.  Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis.

Authors:  Stéphanie Gout; Pierre-Luc Tremblay; Jacques Huot
Journal:  Clin Exp Metastasis       Date:  2007-09-21       Impact factor: 5.150

7.  Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP.

Authors:  Subhash Basu; Rui Ma; Brian Mikulla; Mathew Bradley; Christopher Moulton; Manju Basu; Sipra Banerjee; Jin-ichi Inokuchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 8.  Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).

Authors:  Ja Hye Myung; Sin-Jung Park; Andrew Z Wang; Seungpyo Hong
Journal:  Adv Drug Deliv Rev       Date:  2017-12-13       Impact factor: 15.470

9.  The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.

Authors:  K Leckel; W-D Beecken; D Jonas; E Oppermann; M C Coman; K-F Beck; J Cinatl; N P Hailer; M K H Auth; W O Bechstein; M Shipkova; R A Blaheta
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 10.  Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.

Authors:  Magdalena Thurin
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.